Anzeige
Meldung des Tages: Strom schlägt Bitcoin – Die eigentliche Schlacht im Bitcoin-Markt wird auf der Stromrechnung entschieden

Novo-Nordisk Aktie (ADR) News

Aktie
WKN:  866931 ISIN:  US6701002056 US-Symbol:  NVO Branche:  Pharmazeutika Land:  Dänemark
39,08 $
-0,34 $
-0,86%
33,362 € 17:29:22 Uhr
Depot/Watchlist
Marktkapitalisierung *
150,01 Mrd. €
Streubesitz
89,76%
KGV
27,28
Dividende
1,51 EUR
Dividendenrendite
3,63%
Faktor
1
Originalaktie
DK0062498333
Weiter abwärts? Short handeln - Jetzt mit Hebel 5,84: WA07R3
Werbung

Novo-Nordisk Aktie (ADR) News

10.08.25 - PR Newswire
NVO Investors Have Opportunity to Lead Novo Nordisk A/S Securities Fraud Lawsuit
NVO Investors Have Opportunity to Lead Novo Nordisk A/S Securities Fraud Lawsuit PR Newswire
08.08.25 - PR Newswire
SHAREHOLDER ACTION REMINDER: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Novo Nordisk
SHAREHOLDER ACTION REMINDER: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Novo Nordisk PR Newswire
07.08.25 - PR Newswire
NVO INVESTOR ALERT: Bronstein, Gewirtz & Grossman LLC Announces that Novo Nordisk A/S Investors with Substantial Losses Have Opportunity to Lead Class Action Lawsuit
NVO INVESTOR ALERT: Bronstein, Gewirtz & Grossman LLC Announces that Novo Nordisk A/S Investors with Substantial Losses Have Opportunity to Lead Class Action Lawsuit ...
07.08.25 - PR Newswire
Investors who lost money on Novo Nordisk A/S(NVO) should contact The Gross Law Firm about pending Class Action - NVO
Investors who lost money on Novo Nordisk A/S(NVO) should contact The Gross Law Firm about pending Class Action - NVO PR Newswire
06.08.25 - PR Newswire
INVESTOR ALERT: Pomerantz Law Firm Reminds Investors with Losses on their Investment in Novo Nordisk A/S of Class Action Lawsuit and Upcoming Deadlines - NVO
INVESTOR ALERT: Pomerantz Law Firm Reminds Investors with Losses on their Investment in Novo Nordisk A/S of Class Action Lawsuit and Upcoming Deadlines - NVO PR ...
06.08.25 - ARIVA.DE Redaktion
Dieses Biotech-Unternehmen schlägt Bayer, Evotec, Novo Nordisk & Co. um Längen!
Während Anlegerinnen und Anleger verzweifelt auf einen Turnaround der Aktien von Bayer, Evotec und Novo Nordisk warten, liefert dieser Rivale konstant Gewinne.
06.08.25 - PR Newswire
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Novo Nordisk A/S - NVO
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Novo Nordisk A/S - NVO PR Newswire
05.08.25 - PR Newswire
NVO Investors Have Opportunity to Lead Novo Nordisk A/S Securities Fraud Lawsuit
NVO Investors Have Opportunity to Lead Novo Nordisk A/S Securities Fraud Lawsuit PR Newswire
05.08.25 - PR Newswire
Berger Montague PC Announces Class Action Filed Against Novo Nordisk A/S (NYSE: NVO) for Alleged Securities Violations
Berger Montague PC Announces Class Action Filed Against Novo Nordisk A/S (NYSE: NVO) for Alleged Securities Violations PR Newswire
05.08.25 - PR Newswire
Lost Money on Novo Nordisk A/S(NVO)? Join Class Action Suit Seeking Recovery - Contact Levi & Korsinsky
Lost Money on Novo Nordisk A/S(NVO)? Join Class Action Suit Seeking Recovery - Contact Levi & Korsinsky PR Newswire
03.08.25 - PR Newswire
Faruqi & Faruqi Reminds Novo Nordisk Investors of The Pending Class Action Lawsuit With a Lead Plaintiff Deadline of September 30, 2025 - NVO
Faruqi & Faruqi Reminds Novo Nordisk Investors of The Pending Class Action Lawsuit With a Lead Plaintiff Deadline of September 30, 2025 - NVO PR Newswire
31.07.25 - PR Newswire
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Novo Nordisk A/S - NVO
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Novo Nordisk A/S - NVO PR Newswire
10.07.25 - ARIVA.DE Redaktion
Novo Nordisk: Langsam müssen sich die Bullen mal ins Zeug legen!
Die Aktie von Novo Nordisk steckt nach einer zwischenzeitlich dynamischen Erholung in einer Konsolidierung fest. Zwar ist die Ausgangslage konstruktiv, aber allzu viel Zeit sollten ...
26.06.25 - PR Newswire
Novo Nordisk continues efforts to support patient access to authentic, FDA approved Wegovy® and prioritize patient safety
Novo Nordisk continues efforts to support patient access to authentic, FDA approved Wegovy® and prioritize patient safety PR Newswire
23.06.25 - PR Newswire
Novo Nordisk terminates collaboration with Hims & Hers Health, Inc. due to concerns about their illegal mass compounding and deceptive marketing
Novo Nordisk terminates collaboration with Hims & Hers Health, Inc. due to concerns about their illegal mass compounding and deceptive marketing PR Newswire
16.06.25 - inv3st.de
Novo Nordisk, dynaCERT, Verbio – Keine Panik!
Nein, diese Woche stand nicht Donald Trump im Mittelpunkt, obwohl der US-​Präsident anlässlich seines 79. Wiegenfestes zu einer Parade lud. Vielmehr prägte die kriegerische ...
22.05.25 - PR Newswire
New Novo Nordisk initiatives support patient access to authentic, FDA-approved Wegovy® as federal ban on mass compounding of "semaglutide" takes effect
New Novo Nordisk initiatives support patient access to authentic, FDA-​approved Wegovy® as federal ban on mass compounding of "semaglutide" takes effect PR Newswire
20.05.25 - PR Newswire
From Retina Scans to Cancer Trials, AI Is Taking Over the Exam Room
From Retina Scans to Cancer Trials, AI Is Taking Over the Exam Room PR Newswire
20.05.25 - PR Newswire
From Retina Scans to Cancer Trials, AI Is Taking Over the Exam Room
From Retina Scans to Cancer Trials, AI Is Taking Over the Exam Room PR Newswire

Newssuche

Videos

newspaper
20.04.26 +0,17%
Technical Trading: GBP Long im Trend
GBP/USD Long Typ: Open End Turbo WKN: VV7A4S Hebel: 10 Laufzeit: OpenEnd Einstieg: Market ... Mehr »